Picard Medical is trading at $4.92, up 13.77%, with no clear company-specific announcement identified for October 2. - The broader market is higher after September payrolls came in at 29,000, below expectations, easing near-term rate-hike concerns. - Reuters reported major U.S. indexes rose following the jobs report. The risk-on backdrop may be supportive, but does not by itself explain Picard Medical’s much larger gain.